Vertaling van "affects 13 of those " (Nederlands → Frans) :

Analysis according to level of education Depressive disorders are most frequent amongst the least educated layers of the population (it affects 13% of those with primary education only, as opposed to 5% of those with higher education).
Analyse par niveau d’instruction Les troubles dépressifs se concentrent davantage dans les couches de population les moins scolarisées (13 % chez les diplômés du primaire contre 5 % chez les diplômés du supérieur).

Those bereaved by suicide possibly form the largest group affected by suicide and yet, they are often forgotten.
Les proches après un suicide constituent un groupe important et sont pourtant souvent oubliés.

In contrast, the 55-74 year-olds are less affected by psychological morbidity, whatever its intensity, than those belonging to the other age groups.
En revanche, les personnes de 55 à 74 ans sont moins nombreuses que dans les autres groupes d’âge à connaître un mal-être psychologique, quelle que soit l’intensité.

As a rule, the psychological state of the 35-44 year-olds is found to be less favourable, especially as far as the more severe [4+] affections are concerned, which hit 16% of those belonging to this age group.
On remarque des dispositions psychologiques généralement moins favorables pour le groupe d’âge de 35-44 ans, surtout au regard des affections plus sévères [4+], qui atteignent 16 % des personnes de cet âge.

- The stigmatisation experienced by patients suffering from depression LUCAS participates, within the EAAD framework, in an international study (INDIGO) on the stigmatisation and discrimination felt by those affected by psychological problems.
Expériences de stigmatisation vécues par des patients souffrant de dépression Dans le cadre de l’EAAD, LUCAS participe à une étude internationale (INDIGO) sur l’expérience de la stigmatisation et de la discrimination par des personnes ayant des problèmes psychiques.

National mental health policies that should strengthen the value of mental health, recognise and try to solve the great problems affecting mental health in all layers of society: refugees, disaster victims, those marginalised from society, the mentally handicapped, very old and disabled individuals, abused women and children, as well as financially impoverished people. In order to do so, it is necessary to adapt the organisation of the Community accordingly (with regard to mass media, health services, other organisations, industry and business, legislation).
Politiques nationales de santé mentale qui doivent renforcer la valeur de la santé mentale, reconnaître et tenter de résoudre les grands problèmes affectant la santé mentale dans tous les secteurs de la société: réfugiés, victimes de catastrophes, exclus sociaux, handicapés mentaux, personnes très âgées et infirmes, femmes et enfants victimes de mauvais traitement, ainsi que les personnes financièrement démunies; et à cette fin, adapter l’organisation de la Communauté (mass media, services de santé, autres organisations, industries et commerces, législation).

- A combination of drug treatment and psychological treatment is provided to 13,8% of those who seek help for emotional reasons.
- La combinaison d’un traitement médicamenteux et psychologique est offerte à 13,8 % des personnes demandant de l’aide pour des raisons émotionnelles.

An initiative started by the Novartis Foundation for Sustainable Development with Swiss and Swedish development agencies provides support to the Regional Psychosocial Support Initiative (REPSSI), which helps children affected by HIV/AIDS, poverty and conflict in 13 African countries.
En association avec deux organismes d’aide au développement suisse et suédois, la Fondation Novartis pour un développement durable permet de soutenir le projet REPSSI (Regional Psychosocial Support Initiative), lequel vient en aide aux enfants touchés par le sida, la pauvreté ou la guerre dans treize pays africains.

Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.
This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.